Insider trade

Biodesix (BDSX)Director bought ~$247K

Jack W Schuler, Director at Biodesix, bought ~$247K of Biodesix shares.

~$247K
Approx. value · 723K sh @ $0.341
20.9M
Holds after · shares reported
Traded
May 19, 2025
Filed
May 20, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 12, 2025Insider · 5 peopleInsiders: 5 sales (~$1K)
  2. May 13, 2025Insider · 5 peopleInsiders: 5 sales (~$1K)
  3. May 16, 2025InsiderDirector purchased ~$1.07M of BDSX shares in the open market
  4. May 19, 2025 · this disclosureInsiderDirector purchased ~$247K of BDSX shares in the open market

What came next

  1. Aug 13, 2025Insider · 5 peopleInsiders: 5 sales (~$2K)
  2. Aug 29, 2025InsiderDirector purchased ~$1.5M of BDSX shares in the open market
  3. Sep 12, 2025Company filing · Form 8-K · Shareholder rights, Bylaws or charterChanged the rights of its shareholders, and changed its bylaws, charter or fiscal year
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Biodesix

For Biodesix, OQRO holds 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDSX page.

Other recent filings by Jack W Schuler, Director

The full history of Jack W Schuler, Director is on the profile page.

How this filing works

Other disclosures at Biodesix

Everything OQRO holds on this company is on its BDSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data